gefitinib has been researched along with guaifenesin in 2 studies
| Studies (gefitinib) | Trials (gefitinib) | Recent Studies (post-2010) (gefitinib) | Studies (guaifenesin) | Trials (guaifenesin) | Recent Studies (post-2010) (guaifenesin) |
|---|---|---|---|---|---|
| 5,231 | 566 | 2,919 | 11,152 | 362 | 2,987 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Feng, YL; Guan, AY; Wang, BD; Wen, FQ; Xu, ZB | 1 |
1 review(s) available for gefitinib and guaifenesin
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
1 other study(ies) available for gefitinib and guaifenesin
| Article | Year |
|---|---|
[Effect of gefinitib on airway mucus hypersecretion induced by acrolein in rats].
Topics: Acrolein; Animals; ErbB Receptors; Gefitinib; Goblet Cells; Immunohistochemistry; Male; Mucin 5AC; Mucus; Protein Kinase Inhibitors; Quinazolines; Random Allocation; Rats; Rats, Sprague-Dawley; Respiratory Mucosa; Reverse Transcriptase Polymerase Chain Reaction | 2008 |